D.Western Therapeutics Institute, Inc. [4576.T]
TOKYO, Apr 01 (Pulse News Wire) – D.Western Therapeutics Institute, Inc. (4576.T) reported the exercise status of its 13th tranche warrant (with adjustment clause) for March 2026.
The warrants were issued on July 31, 2025. In March, a total of 475,000 shares were delivered based on exercised warrants, representing 4.75% of the total issuance. The exercise ratio was calculated as 4,750 out of the total issuance. At the end of February, there were 13,848 unexercised warrants, which decreased to 9,098 by the end of March. Exercise activity varied throughout the month.
On March 5, 300,000 shares were transferred through warrant exercises at a price of ¥3,000 per share. Additionally, on March 10, 10,000 shares were transferred at a price of ¥100 per warrant, and on March 24 and 25, transfers occurred at prices of 20,000 and ¥10,000 respectively, with corresponding warrant exercises totaling 200 and 100 units. Regarding exercise limitations, the combined delivery stock count stood at 475,000 shares, while the outstanding listed stock count was 45,741,512. The exercise ratio remained within the limit set by the Tokyo Stock Exchange's listing regulations and the Securities Association’s rules, at 1.04%. For more detailed information on the issuance of the 13th tranche warrant, refer to the notice published on July 15, 2025.
🟢 Confidence: High AI-translated content.